- Home
- LEXX vs BGI Comparison
LEXX vs BGI Comparison
Compare LEXX & BGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEXX
- BGI
- Stock Information
- Founded
- LEXX 2004
- BGI 1879
- Country
- LEXX Canada
- BGI Canada
- Employees
- LEXX N/A
- BGI N/A
- Industry
- LEXX Biotechnology: Pharmaceutical Preparations
- BGI
- Sector
- LEXX Health Care
- BGI
- Exchange
- LEXX Nasdaq
- BGI Nasdaq
- Market Cap
- LEXX 23.9M
- BGI 22.7M
- IPO Year
- LEXX N/A
- BGI 2005
- Fundamental
- Price
- LEXX $0.82
- BGI $1.15
- Analyst Decision
- LEXX Strong Buy
- BGI
- Analyst Count
- LEXX 1
- BGI 0
- Target Price
- LEXX $4.00
- BGI N/A
- AVG Volume (30 Days)
- LEXX 1.3M
- BGI 3.3M
- Earning Date
- LEXX 11-25-2025
- BGI 11-26-2025
- Dividend Yield
- LEXX N/A
- BGI N/A
- EPS Growth
- LEXX N/A
- BGI N/A
- EPS
- LEXX N/A
- BGI N/A
- Revenue
- LEXX $615,923.00
- BGI $124,446,731.00
- Revenue This Year
- LEXX $46.98
- BGI N/A
- Revenue Next Year
- LEXX $17.26
- BGI N/A
- P/E Ratio
- LEXX N/A
- BGI N/A
- Revenue Growth
- LEXX 49.85
- BGI N/A
- 52 Week Low
- LEXX $0.77
- BGI $0.56
- 52 Week High
- LEXX $3.28
- BGI $2.31
- Technical
- Relative Strength Index (RSI)
- LEXX 40.14
- BGI 61.02
- Support Level
- LEXX $0.88
- BGI $1.00
- Resistance Level
- LEXX $1.01
- BGI $1.23
- Average True Range (ATR)
- LEXX 0.12
- BGI 0.12
- MACD
- LEXX -0.06
- BGI -0.01
- Stochastic Oscillator
- LEXX 3.11
- BGI 41.59
About LEXX Lexaria Bioscience Corp.
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.
About BGI Birks Group Inc.
Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.